Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: A systematic review and metaanalysis

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 4, 2012, Pages 266.e1-266.e12

  Gallos, Ioannis D ^a   Yap, Jason ^b   Rajkhowa, Madhurima ^a   Luesley, David M ^b   Coomarasamy, Arri ^a   Gupta, Janesh K ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

atypical complex hyperplasia; endometrial cancer; fertility sparing treatment; live births; progestogens

Indexed keywords

ACETYLSALICYLIC ACID; BROMOCRIPTINE; GESTAGEN; GONADORELIN DERIVATIVE; HYDROXYPROGESTERONE; LETROZOLE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; TAMOXIFEN;

BIRTH RATE; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONCEPTION; DRUG TREATMENT FAILURE; ECHOGRAPHY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FOLLOW UP; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; LOW DRUG DOSE; META ANALYSIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OVARY ADENOCARCINOMA; OVARY CANCER; OVULATION INDUCTION; PATIENT SAFETY; PREGNANCY OUTCOME; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TUMOR DIFFERENTIATION;

EID: 84866846627     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.08.011     Document Type: Article

References (48)

1. Office for National Statistics Cancer Statistics registrations: registrations of cancer diagnosed in 2007, England National Statistics (Series MB1 no. 38) 2010 Office for National Statistics London (United Kingdom
2. L.G. Escobedo, N.C. Lee, H.B. Peterson, P.A. Wingo Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women Obstet Gynecol 77 1991 124 128
3. I.D. Gallos, M. Shehmar, S. Thangaratinam, T.K. Papapostolou, A. Coomarasamy, J.K. Gupta Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis Am J Obstet Gynecol 203 2010 547.e1 547.e10
4. I.D. Gallos, O. Ofinran, M. Shehmar, A. Coomarasamy, J.K. Gupta Current management of endometrial hyperplasia - a survey of United Kingdom consultant gynaecologists Eur J Obstet Gynecol Reprod Biol 158 2011 305 307
5. International Society of Gynaecological Pathologists (ISGP) Classification of endometrial hyperplasia A. Blaustein, R.J. Kurman Blaustein's pathology of the female genital tract 5th ed. 2002 Springer New York 467 500
6. K. Slim, E. Nini, D. Forestier, F. Kwiatkowski, Y. Panis, J. Chipponi Methodological index for non-randomized studies (minors): development and validation of a new instrument ANZ J Surg 73 2003 712 716
7. G.D.S.D.A. Matthias Egger Systematic reviews in health care: meta-analysis in context 2nd ed. 2001 BMJ London
8. J.J. Deeks, J.P.T. Higgins, D.G. Altman Analysing data and undertaking meta-analyses (chapter 9) eds J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions, version 5.0.1 [updated September 2008] 2008 The Cochrane Collaboration www.cochrane-handbook.org Accessed Dec. 26, 2011
9. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
10. S. Lewis, M. Clarke Forest plots: trying to see the wood and the trees BMJ 322 2001 1479 1480
11. J.P. Higgins, S.G. Thompson Controlling the risk of spurious findings from meta-regression Stat Med 23 2004 1663 1682
12. J.V. Bokhman, O.F. Chepick, A.T. Volkova, A.S. Vishnevsky Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 20 1985 139 155
13. T.J. Cade, M.A. Quinn, R.M. Rome, D. Neesham Progestogen treatment options for early endometrial cancer BJOG 117 2010 879 884
14. L.R. Duska, A. Garrett, B.R. Rueda, J. Haas, Y. Chang, A.F. Fuller Endometrial cancer in women 40 years old or younger Gynecol Oncol 83 2001 388 393
15. Z. Eftekhar, N. Izadi-Mood, F. Yarandi, H. Shojaei, Z. Rezaei, S. Mohagheghi Efficacy of MA acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients Int J Gynecol Cancer 19 2009 249 252
16. S.E. Elizur, M.E. Beiner, J. Korach, A. Weiser, G. Ben-Baruch, J. Dor Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma Fertil Steril 88 2007 1562 1567
17. W.H. Gotlieb, M.E. Beiner, B. Shalmon Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer Obstet Gynecol 102 2003 718 725
18. H.S. Hahn, S.G. Yoon, J.S. Hong Conservative treatment with progestin and pregnancy outcomes in endometrial cancer Int J Gynecol Cancer 19 2009 1068 1073
19. A.R. Han, Y.S. Kwon, D.Y. Kim Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia Int J Gynecol Cancer 19 2009 147 151
20. M. Imai, T. Jobo, R. Sato, M. Kawaguchi, H. Kuramoto MPA acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations Eur J Gynaecol Oncol 22 2001 217 220
21. P. Jadoul, J. Donnez Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma Fertil Steril 80 2003 1315 1324
22. T. Kaku, H. Yoshikawa, H. Tsuda Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome Cancer Lett 167 2001 39 48
23. Y.B. Kim, C.H. Holschneider, K. Ghosh, R.K. Nieberg, F.J. Montz Progestin alone as primary treatment of endometrial carcinoma in premenopausal women Report of seven cases and review of the literature Cancer 79 1997 320 327
24. G. Laurelli, V.G. Di, C. Scaffa, S. Losito, G.M. Del, S. Greggi Conservative treatment of early endometrial cancer: preliminary results of a pilot study Gynecol Oncol 120 2011 43 46
25. J.F. Le Digabel, C. Gariel, L. Catala, C. Dhainaut, P. Madelenat, P. Descamps [Young women with atypical endometrial hyperplasia or endometrial adenocarcinoma stage I: will conservative treatment allow pregnancy? Results of a French multicentric survey] Gynecol Obstet Fertil 34 2006 27 33
26. S.Y. Lee, M.K. Kim, H. Park The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women J Gynecol Oncol 21 2010 102 105
27. H.Z. Li, X.N. Chen, J. Qiao Letrozole as primary therapy for endometrial hyperplasia in young women Int J Gynaecol Obstet 100 2008 10 12
28. Y. Mao, X. Wan, Y. Chen, W. Lv, X. Xie Outcomes of conservative therapy for young women with early endometrial adenocarcinoma Fertil Steril 93 2010 283 285
29. I. Mazzon, G. Corrado, V. Masciullo, D. Morricone, G. Ferrandina, G. Scambia Conservative surgical management of stage IA endometrial carcinoma for fertility preservation Fertil Steril 93 2010 1286 1289
30. T. Minaguchi, S. Nakagawa, Y. Takazawa Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium Cancer Lett 248 2007 112 122
31. L. Minig, D. Franchi, S. Boveri, C. Casadio, L. Bocciolone, M. Sideri Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women Ann Oncol 22 2011 643 649
32. F.J. Montz, R.E. Bristow, A. Bovicelli, R. Tomacruz, R.J. Kurman Intrauterine progesterone treatment of early endometrial cancer Am J Obstet Gynecol 186 2002 651 657
33. K. Niwa, K. Tagami, Z. Lian, K. Onogi, H. Mori, T. Tamaya Outcome of fertility-preserving treatment in young women with endometrial carcinomas BJOG 112 2005 317 320
34. T. Ota, M. Yoshida, M. Kimura, K. Kinoshita Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger Int J Gynecol Cancer 15 2005 657 662
35. H. Park, J.M. Seok, B.S. Yoon Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium Arch Gynecol Obstet 285 2012 473 478
36. T. Perri, J. Korach, W.H. Gotlieb Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved Int J Gynecol Cancer 21 2011 72 78
37. T.C. Randall, R.J. Kurman Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 Obstet Gynecol 90 1997 434 440
38. M. Signorelli, G. Caspani, C. Bonazzi, V. Chiappa, P. Perego, C. Mangioni Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases BJOG 116 2009 114 118
39. K. Ushijima, H. Yahata, H. Yoshikawa Multicenter phase II study of fertility-sparing treatment with MPA acetate for endometrial carcinoma and atypical hyperplasia in young women J Clin Oncol 25 2007 2798 2803
40. C.B. Wang, C.J. Wang, H.J. Huang Fertility-preserving treatment in young patients with endometrial adenocarcinoma Cancer 94 2002 2192 2198
41. D.T. Wheeler, R.E. Bristow, R.J. Kurman Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins Am J Surg Pathol 31 2007 988 998
42. T. Yahata, K. Fujita, Y. Aoki, K. Tanaka Long-term conservative therapy for endometrial adenocarcinoma in young women Hum Reprod 21 2006 1070 1075
43. K. Yamazawa, M. Hirai, A. Fujito Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer Hum Reprod 22 2007 1953 1958
44. Y.C. Yang, C.C. Wu, C.P. Chen, C.L. Chang, K.L. Wang Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer Gynecol Oncol 99 2005 287 293
45. M. Yu, K. Shen, J.X. Yang Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women Chung Hua Fu Chan Ko Tsa Chih 41 2006 242 245
46. L. Chiva, F. Lapuente, L. Gonzalez-Cortijo Sparing fertility in young patients with endometrial cancer Gynecol Oncol 111 2008 S101 S104
47. I.D. Gallos, J.K. Gupta What about the relapse of endometrial hyperplasia? Eur J Obstet Gynecol Reprod Biol 2011 In Press; http://dx.doi.org/10.1016/j.bbr.2011.03.031
48. C. An-Shine, C. Angel, W. Chin-Jung, L. Chyong-Huey, W. Hein-Shin Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review Taiwan J Obstet Gynecol 1 2011 62 66